(Q42998898)

English

Utility of early testing for HCV viremia as predictive factor of sustained response during interferon or interferon plus ribavirin treatment

scientific article published in May 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Utility of early testing for HCV viremia as predictive factor of sustained response during interferon or interferon plus ribavirin treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

author name string

Castro FJ

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Esteban JI

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sauleda S

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Viladomiu L

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dragon EA

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Esteban R

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Guardia J

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

843-849

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with interferon-alpha by monitoring the response according to viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a quantitative PCR assay for monitoring HCV viraemia levels in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980255-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(00)80255-X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42998898&oldid=2110317035"